The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients With Head and Neck Cancer Undergoing Radiation Therapy
NCT05457478 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2025-01-24
Summary
This clinical trial studies the use of "smart" body-weight scales to monitor weight and nutrition among patients with head and neck cancer undergoing radiation therapy. Malnutrition affects 30-50% of patients diagnosed with head and neck cancer, and approximately 30% of patients have malnutrition prior to diagnosis. "Smart" body weight scales can possibly make self-weighing easier, faster, and more accurate through weight recordings through mobile applications available for "smart" scales. This has the potential to maximize nutritional guidance through quick weight updates, possibly delaying or removing the use of patient enteral feeding (tube feeding). By avoiding or minimizing the use of enteral feeding during radiation therapy, the risk of long-term tube dependence and swallowing ability complications may be reduced.
Conditions
- Head and Neck Squamous Cell Carcinoma
- Malignant Head and Neck Neoplasm
Interventions
- OTHER
-
Medical Device Qardio® smart scale Usage and Evaluation
Weight monitored using a Qardio® smart scale
- OTHER
-
Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
Cambia Health Foundation
collaborator OTHER -
Oregon Health and Science University
collaborator OTHER -
OHSU Knight Cancer Institute
lead OTHER
Principal Investigators
-
Ravi Chandra · OHSU Knight Cancer Institute
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-01-13
- Primary Completion
- 2023-09-13
- Completion
- 2023-09-13
Countries
- United States
Study Locations
More Related Trials
-
Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial
NCT05418842 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
NCT02388932 ·Status: TERMINATED ·Phase: NA
-
Quad Shot Radiotherapy in Combination With Immune Checkpoint Inhibition
NCT04454489 ·Status: COMPLETED ·Phase: PHASE2
-
"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
NCT04373642 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck
NCT01952821 ·Status: COMPLETED
-
App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tumors During and After Radio(Chemo)Therapy
NCT06367257 ·Status: RECRUITING ·Phase: NA
-
Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma Outcomes
NCT04253808 ·Status: COMPLETED ·Phase: NA
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
NCT00014118 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NCT05050162 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
NCT04671667 ·Status: RECRUITING ·Phase: PHASE2
-
Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck
NCT05721755 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effect of Prehabilitation on Head and Neck Cancer Patients
NCT06593639 ·Status: RECRUITING ·Phase: NA
-
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
NCT04333537 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
NCT00002555 ·Status: COMPLETED ·Phase: PHASE3
-
Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers
NCT04747054 ·Status: RECRUITING ·Phase: PHASE3
-
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
NCT01706939 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
NCT07156227 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Radiotherapy Plus Panitumumab Compared to Chemoradiotherapy With Unresected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00547157 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
NCT07022470 ·Status: RECRUITING ·Phase: PHASE2
-
Low-Carbohydrate Normocaloric Diet in Patients With Head and Neck Carcinoma (HNC)
NCT02555176 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer
NCT03247712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
NCT01098669 ·Status: COMPLETED
-
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
NCT07121595 ·Status: RECRUITING ·Phase: PHASE2
-
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
NCT03010150 ·Status: RECRUITING
-
Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer
NCT00544414 ·Status: COMPLETED ·Phase: PHASE2